Related references
Note: Only part of the references are listed.Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance:: a population-based study
J. Sundstrom et al.
HEART (2008)
Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal pepticle levels in the community
Thomas J. Wang et al.
AMERICAN HEART JOURNAL (2007)
Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure
Begona Lopez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
SH Ahmed et al.
CIRCULATION (2006)
Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events
Johan Sundstrom et al.
CURRENT OPINION IN LIPIDOLOGY (2006)
Plasma storage at-80°C does not protect matrix metalloproteinase-9 from degradation
D Rouy et al.
ANALYTICAL BIOCHEMISTRY (2005)
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures:: the Framingham heart study
J Sundström et al.
EUROPEAN HEART JOURNAL (2004)
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures -: The Framingham Heart Study
J Sundström et al.
CIRCULATION (2004)
Serum levels of matrix metalloproteinases and tumor necrosis factor-α in patients with idiopathic dilated cardiomyopathy and effect of Carvedilol on these levels
T Ohtsuka et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice
EEJM Creemers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Cardiac remodelling in end stage heart failure:: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP
D Reinhardt et al.
HEART (2002)
TIMP-1 - A marker of left ventricular diastolic dysfunction and fibrosis in hypertension
MM Lindsay et al.
HYPERTENSION (2002)
Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9
AM Romanic et al.
CARDIOVASCULAR RESEARCH (2002)
Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload
AL Chancey et al.
CIRCULATION (2002)
Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats
Y Iwanaga et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction
ML Lindsey et al.
CIRCULATION (2002)
Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy
PM Timms et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure
FG Spinale et al.
CIRCULATION (2000)
Share Paper
